MyBios Gmbh

About MyBios Gmbh

myBIOS GmbH is an innovative biotechnology company built on more than 40 years of scientific expertise. The company specializes in the production of high-value recombinant proteins, including alternative proteins, industrial enzymes, and bioactive peptides, serving a broad range of industrial sectors such as pharmaceuticals, food and feed, cosmetics or materials. At myBIOS, our mission is to redefine the future of recombinant protein production through our proprietary methanol-free fermentation technology, utilizing the yeast Pichia pastoris (Komagataella phaffii). This platform, based on non-toxic inducers, establishes new industry standards for safety...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Austria
  • Founded:
    2020
  • On CPHI since:
    2026
  • Employees:
    1 - 24
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Licensee
Start-up
Primary activities
Animal Health
Contract Research Organisation
Cosmetic Ingredients
Nutraceuticals
Technology
Contact info
Show contact info Hide contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
View Exhibitor Profile

Products from MyBios Gmbh (3)

  • Feasibility study

    Product Feasibility study

    This service is designed to deliver a rapid proof of concept for protein production, making it an ideal starting point to evaluate Pichia pastoris as a host system. 

    The Feasibility study can serve as a foundation for advanced strain engineering and high-throughput screening at myBIOS...
  • myPichia Toolbox

    Product myPichia Toolbox

    Ready to revolutionize your in-house protein production? 

    For teams aiming to work independently, we offer a comprehensive Pichia Toolbox that equips you with everything needed for in‑house experimentation including expression vectors, strains and various genetic elements enabling you to perfor...
  • Strain development

    Product Strain development

    Let your production strain development be handled by experts with strong technology to achieve highest yields. 

    We have developed two novel technologies allowing to completely avoid methanol. Our processes build on a combination of inducible promoters, non-toxic inducers and engineered strains....